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Follicular unit extraction (FUE) is a recent and 
widely used surgical procedure for hair restoration 
(1,2). Complications are rarely reported in literature. 
Herein, we report the first case of recipient site ne-
crosis. We used hyperbaric oxygen therapy (HBOT) as 
an adjunctive therapy in this patient in order to re-
strict necrosis area in length and depth and increase 
wound healing. 
A 33-year-old man, referred to our hyperbaric 
medicine department from a different private hos-
pital due to a scalp necrosis after the hair transplan-
tation surgery, which appeared on the first day after 
the operation. The plastic surgeon who performed 
the surgery provided us with the patient history. The 
patient had suffered hair loss localized to the frontal 
and vertex areas and was diagnosed with androgenic 
alopecia Norwood grade III. He underwent hair trans-
plantation surgery with the FUE technique. 
The ring block was administered in the frontal and 
occipital scalp by using a 31-gauge needle, infiltrating 
2% prilocaine hydrochloride with 1:100 000 adrena-
line. After ring anesthesia, tumescent saline solution 
with adrenaline 1:100 000 (1 mL adrenaline / 100 mL 
saline) was then injected in the entire recipient site to 
make it turgid. 
Approximately 1800 grafts were harvested with 
a 1 mm punch and were transplanted to the frontal 
site. Three hours after the surgery, the patient suf-
fered from a pain in the recipient site, and cyanosis was 
found on examination. The cutaneous lesion then rap-
idly evolved into a necrotic appearance (Figure 1, a).  
Figure 1. (a) Appearance of the ischemic findings of the scalp 24 hours after the opera-
tion. (b) Recipient site necrosis on the 10th day after hyperbaric oxygen therapy (HBOT). 
(c) Eschar was totally debrided after 3 weeks of treatment with HBOT. (d) The wound 
was left to secondary healing.
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The patient was referred to our hospital for HBOT 
on the first day after the surgery. On examination, dark 
purple lesions with irregular borders were observed, 
especially on the right side of the frontal region. The 
patient was not a cigarette smoker; standard laborato-
ry tests were normal. The patient was given adjunctive 
HBOT and topical wound care (wet dressings, antisep-
tics, and moisturizes). The patient received a total of 
10 sessions of HBOT until the end of the second week. 
A typical 120 minutes HBOT session was comprised of 
3×25 minutes of oxygen periods at 2.4 atmospheres 
absolute (ATA).
Tumescence in the recipient area can be useful to 
widen the distance from the follicles residing in fat to 
the nerves and larger blood vessels lying just above 
the fascia, provide hemostasis, and decrease bleed-
ing. Effective recipient tumescence can be achieved 
with adrenaline in saline without anesthetic (3). In our 
case, saline with adrenaline 1:100 000 was used with 
tumescent infiltration to recipient site after regional 
block anesthesia.  
Adrenaline has potential side effects. Procaine with 
epinephrine has been reported to cause tissue necro-
sis in “non-end artery” locations such as the upper lip, 
scalp, face, leg, buttock, scrotum, abdomen, and pa-
tella. Therefore, its use must be carefully considered in 
patients. Necrosis is a very rare complication of FUE. 
There is only a single published case report of a necro-
sis of a donor site (1). Our case shows that the necrosis 
of recipient site owing to exaggerated vasoconstrictor 
response to adrenaline in tumescent infiltration. Thus, 
the patient’s previous responses to epinephrine or 
adrenaline should be checked before the procedure 
in order to avoid ischemia or necrosis of the scalp. 
HBOT, which involves the inhalation of pure oxy-
gen at higher atmospheric pressures, is suggested 
to have anti-hypoxic, anti-edema, and anti-infective 
properties (4). In ischemic tissue, HBOT corrects tissue 
hypoxia by increasing partial oxygen tensions in tis-
sues up to 400-500 mmHg at 2.4 atmospheres abso-
lute (ATA) treatment pressure. Urgent HBOT is needed 
in ischemia to prevent necrosis or decrease necrotic 
tissue size in length and depth (5).
In our patient, wound care, topical antibiotic treat-
ment, and adjunctive HBOT were performed over 10 
days (Figure 1, b). HBOT may be beneficial in restrict-
ing the length and depth of the necrosis. Prospective 
randomized controlled trials are needed to confirm 
this hypothesis. 
Dry, dark, and leathery eschar was totally debrided 
after 3 weeks of treatment with HBOT (Figure 1, c). 
The wound was left to secondary healing (Figure 1, d). 
Conventional wound care therapy was resumed.
We concluded that necrosis is very rare but serious 
problem of hair transplantation procedures. Even if 
seen rarely, possible emergence of ischemic complica-
tions must be considered. Doctors and patients need 
to be aware of this risk. 
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